r Kiran Avancha, is the inaugural Chief Innovation Officer for HonorHealth since Jan 2022. He has been with HonorHealth-system for the past 8 years. Prior to that role he successfully ran strategy and operations for HonorHealth Research Institute as their Chief Operations Officer. Under his direction HRI underwent a growth trajectory of 3-fold revenues and grew the team from 70 FTE to 200+ FTEs.

He is a healthcare & biotech entrepreneur, investor, mentor, and advisor for several medical, health-tech and device startups. He recently cofounded Prizm Therapeutics; an Arizona based pediatric rare disease company. Prizm TX is developing a novel gene therapy for the treatment of Allan-Herndon-Dudley syndrome, an X-linked disorder with high unmet medical need. He had a successful exit in his first start-up called ClinSync clinical Research, an oncology based CRO, the first-of-its kind based out of India and spread into 6 countries.

As a PhD trained scientist and a licensed clinical pharmacist (RPh), he has over 16+ years of strategic, clinical, research and business leadership experience in biotech, healthcare innovation, business development, corporate strategy, M&A, and clinical development in industry, healthcare, and academia. Dr Avancha had successfully fundraised over $50M from VCs, PEs, HNIs and health-systems to build programs for both non-profit as well as for-profit sectors.